Clinical trial
A Randomized Comparative Clinical Trial of ZDV + 3TC + ABC (Trizivir) vs Monotherapy With Lopinavir/R (Kaletra) in Patients With Viral Suppression on Previous Treatment With ZDV + 3TC + ABC (Trizivir) for Preventing Lipoatrophy
NCT00865475 is registered in ClinicalTrials.gov with Fundacion SEIMC-GESIDA as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized Comparative Clinical Trial of ZDV + 3TC + ABC (Trizivir) vs Monotherapy With Lopinavir/R (Kaletra) in Patients With Viral Suppression on Previous Treatment With ZDV + 3TC + ABC (Trizivir) for Preventing Lipoatrophy
- Lead sponsor
- Fundacion SEIMC-GESIDA
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- December 31, 2008
- Completion date
- March 31, 2013
- Enrollment
- 38 (actual)
- Sites
- 7
Conditions
As the registry lists them; a condition with its own page is linked.
hiv infection, hiv infections